Sher, Lawrence
36  results:
Search for persons X
?
1

Safety and immunogenicity of a variant-adapted SARS-CoV-2 r..:

de Bruyn, Guy ; Wang, Joyce ; Purvis, Annie...
de Bruyn , G , Wang , J , Purvis , A , Sanchez Ruiz , M , Adhikarla , H , Alvi , S , Bonaparte , M I , Brune , D , Bueso , A , Canter , R M , Ceregido , M A , Deschmukh , S , Diemert , D , Finn , A H R , Forrat , R , Fu , B , Gallais , J , Griffin , P , Grillet , M-H , Haney , O , Henderson , J A , Koutsoukos , M , Launay , O , Martinon Torres , F , Masotti , R , Michael , N L , Park , J , Rivera-Medina , D M , Romanayak , N , Rook , C , Schuerman , L , Sher , L D , Tavares-Da-Silva , F , Whittington , A , Chicz , R M , Gurunathan , S , Savarino , S & Sridhar , S 2023 , ' Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study ' , EClinicalMedicine , vol. 62 , no. 102109 , 102109 . https://doi.org/10.1016/j.eclinm.2023.102109.  , 2023
 
?
 
?
4

Erratum: Continuous and Daily Oral Immunotherapy for Peanut..:

Vickery, Brian P ; Vereda, Andrea ; Nilsson, Caroline...
https://research.rug.nl/en/publications/e03340a1-e185-4c20-957b-46d2598b185f.  , 2022
 
?
 
?
8

Dupilumab shows long-term safety and efficacy in patients w..:

Deleuran, Mette ; Thaçi, Diamant ; Beck, Lisa A...
https://pure.au.dk/portal/da/publications/dupilumab-shows-longterm-safety-and-efficacy-in-patients-with-moderate-to-severe-atopic-dermatitis-enrolled-in-a-phase-3-openlabel-extension-study(7ba7b7fc-2da2-4ed5-8857-cd425ba5c646).html.  , 2020
 
?
10

Dupilumab Efficacy in Patients Stratified by Baseline Treat..:

Pavord, Ian D ; Siddiqui, Salman ; Papi, Alberto...
info:eu-repo/semantics/altIdentifier/doi/10.2147/JAA.S275068.  , 2020
 
?
11

Dupilumab shows long-term safety and efficacy in patients w..:

Deleuran, Mette ; Thaci, Diamant ; Beck, Lisa A...
https://research.rug.nl/en/publications/637b6627-c900-4ce5-8707-e96da5ab271f.  , 2020
 
?
 
?
13

Dupilumab Provides Favorable Safety and Sustained Efficacy ..:

Beck, Lisa A ; Thaçi, Diamant ; Deleuran, Mette...
Beck , L A , Thaçi , D , Deleuran , M , Blauvelt , A , Bissonnette , R , de Bruin-Weller , M , Hide , M , Sher , L , Hussain , I , Chen , Z , Khokhar , F A , Beazley , B , Ruddy , M , Patel , N , Graham , N M H , Ardeleanu , M & Shumel , B 2020 , ' Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis ' , American Journal of Clinical Dermatology , vol. 21 , no. 4 , pp. 567-577 . https://doi.org/10.1007/s40257-020-00527-x.  , 2020
 
?
15

Safety and immunogenicity of a variant-adapted SARS-CoV-2 r..:

Guy de Bruyn ; Joyce Wang ; Annie Purvis...
http://www.sciencedirect.com/science/article/pii/S2589537023002869.  , 2023
 
1-15